doi:10.1007/s12250-018-0061-y

[1]
Wei-wei Gai, Yan Zhang, Di-han Zhou, Yao-qing Chen, Jing-yi Yang, Hui-min Yan, 2011: PIKA Provides an Adjuvant Effect to Induce Strong Mucosal and Systemic Humoral Immunity Against SARS-CoV^*, Virologica Sinica, 26, 81-94. doi: 10.1007/s12250-011-3183-z
[2]
Ruikun Du, Qinghua Cui, Zinuo Chen, Xiujuan Zhao, Xiaojing Lin, Lijun Rong, 2023: Revisiting influenza A virus life cycle from a perspective of genome balance, Virologica Sinica, 38, 1-8. doi: 10.1016/j.virs.2022.10.005
[3]
Mengwei Li, Yuxu Wang, Jing Jin, Jie Dou, Qinglong Guo, Xue Ke, Changlin Zhou, Min Guo, 2021: Inhibitory Activity of Honeysuckle Extracts against Influenza A Virus In Vitro and In Vivo, Virologica Sinica, 36, 490-500. doi: 10.1007/s12250-020-00302-6
[4]
Hai-Yan Yan, Hui-Qiang Wang, Ming Zhong, Shuo Wu, Lu Yang, Ke Li, Yu-Huan Li, 2021: PML Suppresses Influenza Virus Replication by Promoting FBXW7 Expression, Virologica Sinica, 36, 1154-1164. doi: 10.1007/s12250-021-00399-3
[5]
Shijuan Gao, Jiandong Li, Liping Song, Jiaoxiang Wu, Wenlin Huang, 2017: Influenza A virus-induced downregulation of miR-26a contributes to reduced IFNα/β production, Virologica Sinica, 32, 261-270. doi: 10.1007/s12250-017-4004-9
[6]
Jian Chen, Jian Liu, Zhilu Chen, Daobin Feng, Cuisong Zhu, Jun Fan, Shuye Zhang, Xiaoyan Zhang, Jianqing Xu, 2023: Nonmuscle myosin IIA promotes the internalization of influenza A virus and regulates viral polymerase activity through interacting with nucleoprotein in human pulmonary cells, Virologica Sinica, 38, 128-141. doi: 10.1016/j.virs.2022.12.002
[7]
Wenling Wang, Baoying Huang, Xiuping Wang, Wenjie Tan, Li Ruan, 2019: Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats, Virologica Sinica, 34, 583-591. doi: 10.1007/s12250-019-00138-9
[8]
Xiu-ying PU, Jian-ping LIANG, Xue-hong WANG, Tao XU, Lan-ying HUA, Ruo-feng SHANG, Yu LIU, Yan-mei XING, 2009: Anti-Influenza A Virus Effect of Hypericum perforatum L. Extract ^*, Virologica Sinica, 24, 19-27. doi: 10.1007/s12250-009-2983-x
[9]
Meiyue Dong, Yanyan Wang, Ping Li, Zinuo Chen, Varada Anirudhan, Qinghua Cui, Lijun Rong, Ruikun Du, 2023: Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor, Virologica Sinica, 38, 931-939. doi: 10.1016/j.virs.2023.09.003
[10]
Yingying Yu, Qian Wang, Yanli Wei, Junwen Liu, Guangwen Wang, Zhengxiang Wang, Wentao Shen, Lu Han, Chengjun Li, Cao-Qi Lei, Shuai Xu, Qiyun Zhu, 2025: Nucleophosmin 1 inhibits the replication of influenza A virus by competitively binding viral RNA with viral proteins, Virologica Sinica, 40, 388-400. doi: 10.1016/j.virs.2025.04.007
[11]
Shuoxuan Zhao, Yichao Chen, Tianxin Zhang, Yaoyao Gao, Jing Wu, Fangji Yang, Yongxiang Liu, Xuesong Liu, Nan Qi, 2026: Degradation of ACSL3 by influenza A virus shifts unfolded protein response from antiviral defense to viral evasion, Virologica Sinica, 41, 638-650. doi: 10.1016/j.virs.2026.06.008
[12]
Yuhan Gong, Junwen Liu, Wenxuan Ding, Yuxing Yan, Xue Hu, Gary Wong, Huaijie Jia, Zhengxiang Wang, Xin Li, Jiayi Chen, Xin Zhang, Chao Shan, Shuai Xu, Xiaoxia Wang, 2026: Antiviral activity of Saponin C from Liriope muscari against influenza A virus and SARS-CoV-2, Virologica Sinica, 41, 662-675. doi: 10.1016/j.virs.2026.06.002
[13]
Xiwen Zhao, Xuan Dai, Fuyi Wang, Chenyang Li, Xun Song, Yingying Han, Chaowei Zhang, Lu Wang, Zhendan He, Rongping Zhang, Liang Ye, 2025: Artemisia annua L. leaf extracts suppress influenza virus infection by targeting the viral nucleoprotein and blocking mitochondria-mediated apoptosis, Virologica Sinica, 40, 247-259. doi: 10.1016/j.virs.2025.03.001
[14]
Mingkun Wu, Liru Guo, Mei Kong, Ming Zou, Xiaochang Liu, Xiaoyan Li, 2025: Epidemiological and genomic surveillance of influenza A virus (pdm09 H1N1 and H3N2) strains from 2017 to 2025 in Tianjin, China, Virologica Sinica, 40, 535-545. doi: 10.1016/j.virs.2025.07.011
[15]
Xianmiao Ye, Junnan Lu, Zirong Han, Zhishan Fan, Xinru Hu, Lichuang Jiao, Lisha Deng, Wenming Liu, Junqi Liu, Weiqi Pan, Ling Chen, Liqiang Feng, Caijun Sun, 2026: A semi-replicating VSV (srVSV)-based platform for developing broad-spectrum mucosal vaccines against influenza A viruses, Virologica Sinica, 41, 423-438. doi: 10.1016/j.virs.2026.04.004
[16]
Liping Ma, Huabin Zheng, Xianliang Ke, Rui Gui, Zhongzi Yao, Jiasong Xiong, Quanjiao Chen, 2024: Mutual antagonism of mouse-adaptation mutations in HA and PA proteins on H9N2 virus replication, Virologica Sinica, 39, 56-70. doi: 10.1016/j.virs.2023.11.004
[17]
Chong Wang, Bingyu Guo, Yilin Li, Xi Zhou, Zongqiang Cui, Yujie Ren, 2026: EV-A71 induces GSDME-dependent T-cell pyroptosis: A novel mechanism and MeCbl therapeutic potential, Virologica Sinica, 41, 651-661. doi: 10.1016/j.virs.2026.05.006
[18]
Ningning Ge, Jin Sun, Zhihua Liu, Jiayi Shu, Huimin Yan, Zhihua Kou, Yu Wei, Xia Jin, 2022: An mRNA vaccine encoding Chikungunya virus E2-E1 protein elicits robust neutralizing antibody responses and CTL immune responses, Virologica Sinica, 37, 266-276. doi: 10.1016/j.virs.2022.01.032
[19]
Jieliang Chen, Zhenghong Yuan, 2014: Interplay between hepatitis B virus and the innate immune responses: implications for new therapeutic strategies, Virologica Sinica, 29, 17-24. doi: 10.1007/s12250-014-3412-3
[20]
Yu Zhao, Chen Ma, Jie Yang, Xiufen Zou, Zishu Pan, 2021: Dynamic Host Immune and Transcriptomic Responses to Respiratory Syncytial Virus Infection in a Vaccination-Challenge Mouse Model, Virologica Sinica, 36, 1327-1340. doi: 10.1007/s12250-021-00418-3